All about ebola virus

The shareholders of Telefonaktiebolaget LM Ericsson (reg. no 556016-0680) (the "Company" or "Ericsson") are invited to participate in the Annual General Meeting of shareholders ("AGM") to be held on Tuesday, March 25, 2025 at 1 p.m. CET at the...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (the "Company"), reports that it has filed...

The MNA Board of Directors ? registered nurses and healthcare professionals elected by their 25,000 MNA colleagues ? express our profound distress and condemnation of recent actions taken by the federal administration. We have been monitoring the...

CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in Dubai from February 11-13. Dr Yu Xuefeng, Chairman and Chief Executive Officer , along with Ms Wang Jing,...

Between February 10, 2025, and February 14, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2024 and provided an...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu virus H5N1...

Conduent Incorporated , a global technology-led business solutions and services company, today announced that the Oklahoma State Department of Health (OSDH) has selected the company's Maven® Disease Surveillance & Outbreak Management System to...

Between February 3, 2025, and February 7, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

In September 2024, SKF announced the decision to initiate a separation of its Automotive business with the objective of a separate listing on Nasdaq Stockholm through a Lex Asea distribution to its shareholders. As the separation process continues,...

Today, SUCCESS® magazine announced the winner and finalists of the 2024 SUCCESS® Women of Influence awards. This recognition honors trailblazing women who have made a remarkable impact on their communities, industries, and the lives of others. The...

The Centers for Disease Control and Prevention (CDC) reports that uncontrolled hypertension is a leading cause of cardiovascular disease deaths. Many people don't know they have high blood pressure because it usually has no signs or symptoms. However...

The Centers for Disease Control and Prevention (CDC) reports that uncontrolled hypertension is a leading cause of cardiovascular disease deaths. Many people don't know they have high blood pressure because it usually has no signs or symptoms. However...

Integral Molecular, a leader in antibody discovery technologies, is proud to announce that the FDA has accepted their Membrane Proteome Arraytm (MPA) Qualification Plan for advancement as a Drug Development Tool (DDT) to assess antibody binding...

Report with market evolution powered by AI - The global managed services market size is estimated to grow by USD 217 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  11.3%  during the forecast period....

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the initiation of a Phase 2 clinical study to evaluate the efficacy of opaganib[3] in combination with darolutamide[4] in men with metastatic...

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants have been vaccinated with an investigational Ebola...

According to a new market research report titled, 'Burn Care Market Size, Share, Forecast, & Trends Analysis by Offering (Topical Agents, Dressings [Advanced {Foam, Hydrocolloid, Alginate, Collagen, Hydrogel}, Traditional]), Burn Type (First, Second,...

Between January 27, 2025, and January 31, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Due to a conversion of shares from Series A to Series B in accordance with AB SKF's Articles of Association, the Company confirms the following. As per 31 January 2025 there are a total of 455,351,068 shares in AB SKF, out of which 28,938,999 shares...

Report with market evolution powered by AI - The global managed services market size is estimated to grow by USD 217 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  11.3%  during the forecast period....

Q4 2024 Net sales: SEK 24,725 million (24,438)Organic growth: ?3.1% (?1.9%), driven by lower market demand mainly in Europe and China, while Americas and India & Southeast Asia are showing positive sales development.Adjusted operating profit: SEK...

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. MALMÖ, SE / ACCESS Newswire / January 30, 2025 / Ascelia Pharma (STO:ACE) The...

Report with the AI impact on market trends - The global vaccines market size is estimated to grow by USD 193.7 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of almost 23%  during the forecast period....

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and...

SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today,...

"For the full year 2024, net sales amounted to SEK 526.8 billion (552.3) and the adjusted operating income to SEK 65.7 billion (78.2), with an adjusted operating margin of 12.5% (14.0). Return on capital employed in the Industrial Operations was...

SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral...

Between January 20, 2025, and January 24, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...